Literature DB >> 17179712

A new subtype classification of ischemic stroke based on treatment and etiologic mechanism.

Sang Won Han1, Seo Hyun Kim, Jong Yun Lee, Chong Kyu Chu, Jae Hoon Yang, Ha Young Shin, Hyo Suk Nam, Byung In Lee, Ji Hoe Heo.   

Abstract

A new subtype classification of ischemic stroke was developed to reflect recent therapeutic strategies as well as evolving concepts of stroke definitions and mechanisms. In 200 consecutive patients with acute ischemic stroke, the inter-rater reliability and proportion of subtypes of the new classification system were assessed and compared with those of the Trial of ORG 10172 in the Acute Stroke Treatment (TOAST) classification. The most frequent subtype of the new classification was atherothrombosis (n = 80, 40%), followed by stroke of undetermined etiology (n = 54, 27%), small artery disease (n = 33, 16.5%), cardioembolism (n = 26, 13%), and stroke of other determined etiology (n = 7, 3.5%). Three raters agreed to the stroke subtype diagnosis in 165 out of 200 cases and the overall kappa value was excellent (kappa = 0.82). The new classification system for brain infarction was easy to use and had high inter-rater reliability. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 17179712     DOI: 10.1159/000098059

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  45 in total

1.  The relationship between the polymorphism of SG13S114 A/T in ALOX5AP gene and the vulnerability of carotid atherosclerosis in Chinese Han population.

Authors:  Xiaoping Jin; Yinglei He; Min Zhu; Xianfang Lin; Qiuyue Chen; Zhao Han; Xiaoya Huang; Feng Wang
Journal:  Int J Clin Exp Med       Date:  2010-01-01

2.  Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2.

Authors:  Xingyang Yi; Zhao Han; Qiang Zhou; Wen Cheng; Jing Lin; Chun Wang
Journal:  Clin Appl Thromb Hemost       Date:  2016-09-16       Impact factor: 2.389

3.  Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke.

Authors:  Xingyang Yi; Qiang Zhou; Chun Wang; Jing Lin; Ping Liu; Cheng Fu
Journal:  Eur J Clin Pharmacol       Date:  2017-01-13       Impact factor: 2.953

4.  Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

Authors:  Jing Lin; Zhao Han; Chun Wang; Xingyang Yi; Zhenxiao Chai; Qiang Zhou; Ruyue Huang
Journal:  Eur J Clin Pharmacol       Date:  2018-05-26       Impact factor: 2.953

5.  Cytochrome 4A11 Genetic Polymorphisms Increase Susceptibility to Ischemic Stroke and Associate with Atherothrombotic Events After Stroke in Chinese.

Authors:  Biao Zhang; Xingyang Yi; Chun Wang; Duanxiu Liao; Jing Lin; Lifen Chi
Journal:  Genet Test Mol Biomarkers       Date:  2015-03-03

6.  Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

Authors:  Xingyang Yi; Qiang Zhou; Chun Wang; Jing Lin; Zhenxiao Chai
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

7.  The incidence of venous thromboembolism following stroke and its risk factors in eastern China.

Authors:  Xingyang Yi; Jing Lin; Zhao Han; Xudong Zhou; Xiaotong Wang; Jiguang Lin
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

8.  Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.

Authors:  Duanxiu Liao; Xingyang Yi; Biao Zhang; Qiang Zhou; Jing Lin
Journal:  Genet Test Mol Biomarkers       Date:  2016-03-09

9.  Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.

Authors:  Xingyang Yi; Chun Wang; Ping Liu; Cheng Fu; Jing Lin; Yiming Chen
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

10.  Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.

Authors:  Alexis N Simpkins; R Daniel Rudic; Derek A Schreihofer; Sid Roy; Marlina Manhiani; Hsing-Ju Tsai; Bruce D Hammock; John D Imig
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.